Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04234490
Other study ID # Longitudinal PNIQ
Secondary ID
Status Completed
Phase
First received
Last updated
Start date March 2, 2020
Est. completion date March 23, 2022

Study information

Verified date May 2022
Source University of Manchester
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Patients with type 3 intestinal failure are completely reliant on artificial feeding and often manage this at home; home parenteral nutrition (HPN). HPN therapy is life saving for these patients. The Parenteral Nutrition Impact Questionnaire (PNIQ) is a proven tool for measuring quality of life when receiving HPN. This study will recruit HPN patients across the United Kingdom (UK) and ask them to complete the PNIQ survey at several different time points. This will assess the impact of HPN over time. Family members involved in the participants HPN care will also be asked to complete a carer burden survey (at one time point) to assess the impact of HPN on carers.


Description:

Providing a person with food through a vein is known as parenteral nutrition (PN) or artificial tube feeding. This process is used when nutrients from food can't be taken in by the intestine (intestinal failure). Patients with type 3 intestinal failure are completely reliant on artificial feeding and often manage this at home; home parenteral nutrition (HPN). HPN therapy is life saving for these patients. It is important to assess patients quality of life and their own reported effects of the HPN. The Parenteral Nutrition Impact Questionnaire (PNIQ) is a proven tool for measuring quality of life when receiving HPN. A recent study involving the use of the PNIQ in multiple hospitals in the UK, showed that those on fewer nights of HPN had better quality of life than those on more nights of HPN. Whilst this was useful for looking at quality of life at one time point, it is now important to assess change in quality life over time and any impact on family members quality of life. This study will recruit HPN patients across the UK and ask them to complete the PNIQ survey at several different time points. This will assess the impact of HPN over time. Family members involved in the participants HPN care will also be asked to complete a carer burden survey (at one time point) to assess the impact of HPN on carers. The study is being funded by Shire Pharmaceuticals Ltd.


Recruitment information / eligibility

Status Completed
Enrollment 912
Est. completion date March 23, 2022
Est. primary completion date March 23, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Patients: - All people in receipt of HPN including new patients - Those 18 years and over. Carers: - A family member or person involved in the healthcare of the participating patient. (We will ask patients to nominate their closest family member who in their opinion is potentially most effected by the parenteral feeding.) - Those 18 years and over. Exclusion Criteria: Patients: - Cannot give informed consent - Cannot read or write in English. Carers: • Family members not directly involved with caring for participants

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Parenteral nutrition
Impact of parenteral nutrition on patient quality of life over time and impact on carer burden

Locations

Country Name City State
United Kingdom University of Manchester Manchester

Sponsors (2)

Lead Sponsor Collaborator
University of Manchester Shire International GmbH

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patient reported outcomes Change in Patient reported outcomes (PNIQ score) in people receiving HPN. Score from 0-20, with 0 being high Quality of life and 20 being low quality of life. Baseline, five, 10 and 15 months post entry
Secondary Carer burden Caregiver burden (carer burden survey) in family members/close friends providing HPN healthcare to a patient receiving HPN. Score from 0-84, with 0 being no symptoms and 84 being very severe symptoms Baseline
Secondary Length of time receiving HPN Amount of time the patient has been receiving HPN (months/years) Baseline, five, 10 and 15 months post entry
Secondary Change in number of weekly HPN infusions How often the patient is connected to an infusion each week (numerical) Baseline, five, 10 and 15 months post entry
Secondary Change in number of hours connected to HPN infusions each night How many hours the patient is connected to an infusion each night (hours) Baseline, five, 10 and 15 months post entry
See also
  Status Clinical Trial Phase
Recruiting NCT03606863 - Peripheral Parenteral Nutrition vs Conventional Fluid in Colorectal Resection in ERAS Phase 3
Completed NCT00451646 - Study Comparing the Safety and Tolerance of SMOFlipid 20% in Long-term Treatment With Parenteral Nutrition Phase 3
Completed NCT04006730 - Analysis of the Pharmaceutical Validation of Picc Line Installation Requests at the Nîmes University Hospital
Enrolling by invitation NCT06161350 - The Multi-disciplinary Approach of Children With Feeding Difficulties and Tube Feeding in UZB Between 2000 and 2021
Completed NCT04234152 - Complete Shielding of Multivitamins to Reduce Toxic Peroxides in the Parenteral Nutrition: A Pilot Study N/A
Completed NCT00672854 - Study Comparing a Soybean Oil-Based With an Olive Oil-Based Lipid Emulsion in ICU Patients Requiring TPN Phase 2/Phase 3
Active, not recruiting NCT01839617 - Study Comparing Early and Late Nutrition in Cancer Patients Undergoing Abdominal Surgery N/A
Completed NCT05299099 - Clinical Trial to Evaluate the Safety and Efficacy of IN-C006 Inj. Compared With RCN301 Phase 3
Withdrawn NCT02463812 - Lipid Infusion Following Major Surgery N/A
Completed NCT04816734 - Initial Parenteral Nutrition Education of Parent Assessment Plan N/A
Terminated NCT01814956 - Different Lipid Emulsions in Acute Lung Injury Patients Phase 4
Recruiting NCT05519761 - A Retrospective, Observational, Multicenter Study to Evaluate the Safety and Performance of POLYSITE® and SEESITE® Implantable Ports
Completed NCT00321165 - The AOT (Acridine Orange and Taurolidine) Trial Phase 3
Completed NCT00292279 - The Impact of Omega-3 Fat Emulsion on Clinical Outcome of Post-Operative Cancer Patients Phase 3
Recruiting NCT03157245 - Incidence of Deep Vein Thrombosis on Central Venous Catheters in the Post Operative Period of Carcinologic Surgery N/A
Recruiting NCT03693287 - Personalized vs Standardized PN for Preterm Infants >1250g Phase 4
Completed NCT02828150 - Integrative Parenteral Nutrition in Cancer Patients N/A
Completed NCT00798681 - Evaluating the Influence of Ready-to-use (RTU) Parenteral Nutrition in the Clinical Outcome of Patients Study Phase 4
Completed NCT00512629 - Cholestasis Prevention: Efficacy of IV Fish Oil Phase 1
Completed NCT03792100 - Efficacy & Safety of SmofKabiven Emulsion for Infusion vs Hospital Compounded "All in One" for Parenteral Nutrition Phase 3